EB - Psychoactive Drugs III Flashcards

1
Q

What was amphetamine first synthesized from?

A

Ephedrine, a naturally occurring compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the actions of amphetamine? (4)

A
  • Appetite suppressant
  • Euphoria
  • Raised blood pressure
  • Can cause psychosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some clinical uses of amphetamine? (3)

A
  • Weight control
  • Narcolepsy
  • Attention deficit disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Is methamphetamine used clinically?

A

No, methamphetamine is not used clinically.
It is a street drug, more addictive than cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism of action of amphetamine (and methamphetamine)? (3)

A
  • Prevents reuptake of dopamine into the presynaptic terminal.
  • Reverse transport: Amphetamine is taken up into the nerve terminal instead of catecholamines, increasing catecholamine levels in the synaptic space.
  • Results in higher dopamine levels in the synaptic space.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do addictive and aversive drugs affect dopamine? (2)

A
  • Addictive drugs like opiates, ethanol, nicotine, amphetamine, and cocaine increase the release of dopamine in the nucleus accumbens.
  • Aversive drugs do not have this effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the pathways involved in addiction? (2)

A
  • Evidence for common involvement of the limbic system.
  • Dopamine signalling is especially involved, including the VTA projection to the nucleus accumbens.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does dopamine affect the nucleus accumbens and cortex? (3)

A
  • Dopamine has an inhibitory effect on neurons in the nucleus accumbens, which project to the cortex.
  • These neurons are typically inhibitory, meaning they normally reduce activity in the cortex.
  • Increased dopamine activity suppresses these inhibitory neurons, leading to disinhibition of the cortex (i.e., the cortex becomes more active).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the addiction stages?

A

Impulsive stage:
1. Substance use - pleasurable effects (e.g. euphoria)
2. Heavy use - craving the reward (positive reinforcement)

Compulsive stage:
3. Early dependence
4. Late dependence - withdrawal effects occur (negative reinforcement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the long-term changes associated addiction in terms of D receptors? (2)

A
  • D1 receptor activation (more available) causes an upregulation of adenylyl cyclase, converting ATP to cAMP.
  • PKA translocates to the nucleus, phosphorylating CREB, leading to gene expression changes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is epigenetics?

A

Changes in gene expression that aren’t caused by underlying changes to the DNA sequence
Mediate effects of lifetime exposures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are epigenetic changes related to addiction? (2)

A
  • Epigenetic changes, like histone acetylation, alter chromatin structure and gene expression, contributing to addiction.
  • Cocaine can induce histone acetylation in the nucleus accumbens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the loss of CBP affect cocaine-induced behaviors? (2)

A
  • CBP (CREB-binding protein) is a histone acetyltransferase in the NAc.
  • Loss of CBP in the NAc prevents cocaine-induced locomotion and conditioned place preference (CPP), suggesting CBP is necessary for cocaine’s effects on behavior.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of the Cre-LoxP system?

A
  • The Cre-LoxP system allows gene manipulation at specific times.
  • Cre recombinase interacts with LoxP sites to cut out DNA between them.
  • This system is used to create knockouts or activate genes by removing stop codons.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the site-specific epigenetic changes after stimulant exposure? (5)

A
  • Acute stimulant exposure rapidly induces genes like c-fos.
  • Loss of CBP in NAc neurons decreases histone acetylation and alters c-fos expression in response to stimulants.
  • After chronic stimulant exposure, these changes become desensitized.
  • ΔFosB is induced by chronic stimulant use and binds to the c-fos gene.
  • Chronic exposure leads to the loss of H3K9me2 at the Fosb gene, altering gene expression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is the orbitofrontal cortex (OFC) involved in addiction? (5)

A
  • Addiction is associated with decreased OFC activity.
  • Cocaine-addicted subjects show compromised reward systems and decreased OFC glucose metabolism.
  • Downregulation of dopamine D2
  • Deficit could be implicated in relapse
  • Reversal by optogenetic activation restored normal behaviour
17
Q

What is the role of the amygdala in chronic addiction? (4)

A
  • Strong evidence links the amygdala to alcohol use disorder.
  • Unlike cocaine, rats do not self-administer alcohol unless genetically predisposed (e.g., msP rats).
  • Innate or acquired hyperactivity of extrahypothalamic CRF systems is associated with high alcohol preference
  • Corticotropin-releasing factor receptor 1 (CRF1) antagonist, blocks stress-induced relapse-like behaviour
18
Q

What are some potential targets for treating stimulant use disorders? (5)

A
  • Blocking catecholamine reuptake from the synaptic cleft.
  • Targeting the molecular chaperone σ1R.
  • Opioid system
  • GABA transmission
  • psychedelics like psilocybin.
19
Q

What is the sigma-1 receptor (σ1R) and its role in addiction? (4)

A
  • The sigma-1 receptor (σ1R) is an endoplasmic reticulum chaperone protein.
  • It is widely expressed throughout the brain, including the midbrain and striatum.
  • σ1R interacts with methamphetamine and cocaine at relevant concentrations.
  • Exposure to these drugs increases σ1R levels in dopamine transporter (DAT)-expressing brain regions.
20
Q

How does blocking σ1R affect cocaine’s effects? (3)

A
  • Blocking σ1R prevents cocaine-induced conditioned place preference (CPP).
  • It also inhibits cocaine-stimulated locomotion.
  • σ1R siRNA prevents cocaine’s effect in enhancing D1R agonist-induced cAMP production.
21
Q

What is the effect of σ1R activation on methamphetamine? (2)

A
  • σ1R activation decreases methamphetamine-stimulated dopamine efflux without affecting basal dopamine neurotransmission.
  • It reduces methamphetamine-induced locomotion, motivated behavior, and the enhancement of brain reward function.

This makes σ1R a potential target for therapies in addiction treatment.

22
Q

What is psilocybin and its significance in addiction treatment?

A
  • Psilocybin is a non-addictive, serotonergic psychedelic with neuroplasticity-inducing properties.
  • It shows promise in clinical trials for methamphetamine and cocaine-use disorders.
  • For alcohol use disorders, psilocybin has a strong effect in decreasing the number of heavy drinking days.